Literature DB >> 18777586

Role of STAT3 in inflammatory bowel disease.

Ken Sugimoto1.   

Abstract

Signal transducers and activators of transcription 3 (STAT3) play an important role in various autoimmune disorders including inflammatory bowel disease (IBD). Recent studies have revealed that STAT3 activation plays distinctly different roles between innate immune responses and acquired immune responses in colitis. STAT3-mediated activation of acquired immune responses plays a pathogenic role in colitis by enhancing the survival of pathogenic T cells. In contrast, STAT3-mediated activation of innate responses contributes to the suppression of colitis. This review will summarize the current understanding of the roles of STAT3 in IBD and the potential of targeting STAT3 for the treatment of IBD, emphasizing recent observations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18777586      PMCID: PMC2743999          DOI: 10.3748/wjg.14.5110

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  59 in total

1.  Constitutive STAT3 activation in intestinal T cells from patients with Crohn's disease.

Authors:  Paola Lovato; Christine Brender; Jørgen Agnholt; Jens Kelsen; Keld Kaltoft; Arne Svejgaard; Karsten Wessel Eriksen; Anders Woetmann; Niels Ødum
Journal:  J Biol Chem       Date:  2003-03-03       Impact factor: 5.157

Review 2.  Inflammatory bowel disease.

Authors:  Daniel K Podolsky
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

Review 3.  Immune networks in animal models of inflammatory bowel disease.

Authors:  Atsushi Mizoguchi; Emiko Mizoguchi; Atul K Bhan
Journal:  Inflamm Bowel Dis       Date:  2003-07       Impact factor: 5.325

Review 4.  Stats: transcriptional control and biological impact.

Authors:  David E Levy; J E Darnell
Journal:  Nat Rev Mol Cell Biol       Date:  2002-09       Impact factor: 94.444

5.  Generation of regulatory gut-homing human T lymphocytes using ex vivo interleukin 10 gene transfer.

Authors:  Catherine Van Montfrans; Erik Hooijberg; Maria Sol Rodriguez Pena; Esther C De Jong; Hergen Spits; Anje A Te Velde; Sander J H Van Deventer
Journal:  Gastroenterology       Date:  2002-12       Impact factor: 22.682

6.  STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity.

Authors:  Thomas Welte; Samuel S M Zhang; Tian Wang; Zhiyuan Zhang; David G T Hesslein; Zhinan Yin; Arihiro Kano; Yoshiki Iwamoto; En Li; Joseph E Craft; Alfred L M Bothwell; Erol Fikrig; Pandelakis A Koni; Richard A Flavell; Xin-Yuan Fu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-05       Impact factor: 11.205

7.  Leptin: a pivotal mediator of intestinal inflammation in mice.

Authors:  Britta Siegmund; Hans Anton Lehr; Giamila Fantuzzi
Journal:  Gastroenterology       Date:  2002-06       Impact factor: 22.682

8.  Regulation of mucosal immune responses by recombinant interleukin 10 produced by intestinal epithelial cells in mice.

Authors:  Hilde De Winter; Dirk Elewaut; Olga Turovskaya; Margaret Huflejt; Carolyn Shimeld; Amy Hagenbaugh; Scott Binder; Ichiro Takahashi; Mitchell Kronenberg; Hilde Cheroutre
Journal:  Gastroenterology       Date:  2002-06       Impact factor: 22.682

9.  Functional expression of the interleukin-11 receptor alpha-chain and evidence of antiapoptotic effects in human colonic epithelial cells.

Authors:  Stephan Kiessling; Gerhard Muller-Newen; Sandra N Leeb; Martin Hausmann; Heiko C Rath; Jorn Strater; Tanja Spottl; Klaus Schlottmann; Johannes Grossmann; F A Montero-Julian; Jurgen Scholmerich; Tilo Andus; Armin Buschauer; Peter C Heinrich; Gerhard Rogler
Journal:  J Biol Chem       Date:  2003-12-29       Impact factor: 5.157

10.  Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice.

Authors:  Niall C Tebbutt; Andrew S Giraud; Melissa Inglese; Brendan Jenkins; Paul Waring; Fiona J Clay; Sina Malki; Barbara M Alderman; Dianne Grail; Frédéric Hollande; Joan K Heath; Matthias Ernst
Journal:  Nat Med       Date:  2002-09-09       Impact factor: 53.440

View more
  44 in total

Review 1.  Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD.

Authors:  Matthew R Kudelka; Sean R Stowell; Richard D Cummings; Andrew S Neish
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-07-24       Impact factor: 46.802

2.  Over-expression of CXCR4 on mesenchymal stem cells protect against experimental colitis via immunomodulatory functions in impaired tissue.

Authors:  Xingxing Liu; Dongmei Zuo; Heng Fan; Qing Tang; Zhexing Shou; Dan Cao; Zhou Zou
Journal:  J Mol Histol       Date:  2013-10-12       Impact factor: 2.611

Review 3.  Therapeutic potential of curcumin in digestive diseases.

Authors:  Pietro Dulbecco; Vincenzo Savarino
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

Review 4.  Role of genetics in the diagnosis and prognosis of Crohn's disease.

Authors:  Epameinondas V Tsianos; Konstantinos H Katsanos; Vasileios E Tsianos
Journal:  World J Gastroenterol       Date:  2011-12-28       Impact factor: 5.742

Review 5.  Cytokine responses and epithelial function in the intestinal mucosa.

Authors:  Joseph C Onyiah; Sean P Colgan
Journal:  Cell Mol Life Sci       Date:  2016-06-06       Impact factor: 9.261

6.  Intestinal Epithelial Cell Tyrosine Kinase 2 Transduces IL-22 Signals To Protect from Acute Colitis.

Authors:  Eva Hainzl; Silvia Stockinger; Isabella Rauch; Susanne Heider; David Berry; Caroline Lassnig; Clarissa Schwab; Felix Rosebrock; Gabriel Milinovich; Michaela Schlederer; Michael Wagner; Christa Schleper; Alexander Loy; Tim Urich; Lukas Kenner; Xiaonan Han; Thomas Decker; Birgit Strobl; Mathias Müller
Journal:  J Immunol       Date:  2015-10-02       Impact factor: 5.422

7.  Oral treatment with SEW2871, a sphingosine-1-phosphate type 1 receptor agonist, ameliorates experimental colitis in interleukin-10 gene deficient mice.

Authors:  J Dong; H Wang; G Wu; J Zhao; L Zhang; L Zuo; W Zhu; J Gong; Y Li; L Gu; J Li
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

8.  STAT3 genotypic variation and cellular STAT3 activation and colon leukocyte recruitment in pediatric Crohn disease.

Authors:  Tara A Willson; Benjamin R Kuhn; Ingrid Jurickova; Shaina Gerad; David Moon; Erin Bonkowski; Rebecca Carey; Margaret H Collins; Huan Xu; Anil G Jegga; Stephen L Guthery; Lee A Denson
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-07       Impact factor: 2.839

9.  Disruption of astrocyte STAT3 signaling decreases mitochondrial function and increases oxidative stress in vitro.

Authors:  Theodore A Sarafian; Cindy Montes; Tetsuya Imura; Jingwei Qi; Giovanni Coppola; Daniel H Geschwind; Michael V Sofroniew
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

Review 10.  MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma.

Authors:  Xiang Li; Jing Nie; Qian Mei; Wei-Dong Han
Journal:  World J Gastroenterol       Date:  2016-06-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.